Effects of topically applied rapamycin and mycophenolic acid on TNCB-induced atopic dermatitis-like skin lesions in NC/Nga mice.

[1]  M. Wataya-Kaneda,et al.  Topical application of rapamycin ointment ameliorates Dermatophagoides farina body extract‐induced atopic dermatitis in NC/Nga mice , 2014, Experimental dermatology.

[2]  D. Leung,et al.  New era of biologic therapeutics in atopic dermatitis , 2013, Expert opinion on biological therapy.

[3]  S. Cho,et al.  Effect of (E)-2-(3,4-dimethoxyphenyl)-4-oxo-4H-chromen-7-yl-3-(3,4-dimethoxyphenyl) acrylate on the development of atopic dermatitis-like lesions. , 2012, Life sciences.

[4]  R. Bissonnette,et al.  Efficacy and safety of topical WBI‐1001 in patients with mild to severe atopic dermatitis: results from a 12‐week, multicentre, randomized, placebo‐controlled double‐blind trial , 2012, The British journal of dermatology.

[5]  G. K. Khurana Hershey,et al.  Rapamycin Attenuates Airway Hyperreactivity, Goblet Cells, and IgE in Experimental Allergic Asthma , 2011, The Journal of Immunology.

[6]  T. Defloor,et al.  A 3-in-1 Perineal Care Washcloth Impregnated With Dimethicone 3% Versus Water and pH Neutral Soap to Prevent and Treat Incontinence-Associated Dermatitis: A Randomized, Controlled Clinical Trial , 2011, Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society.

[7]  R. Agans,et al.  Systemic Treatment of Pediatric Atopic Dermatitis with Azathioprine and Mycophenolate Mofetil , 2011, Pediatric dermatology.

[8]  D. Simon.  Systemic therapy of atopic dermatitis in children and adults. , 2011, Current problems in dermatology.

[9]  S. K. Yoon,et al.  Effects of topically applied Korean red ginseng and its genuine constituents on atopic dermatitis-like skin lesions in NC/Nga mice. , 2011, International immunopharmacology.

[10]  Y. Choi,et al.  Pep-1 peptide-conjugated elastic liposomal formulation of taxifolin glycoside for the treatment of atopic dermatitis in NC/Nga mice. , 2010, International journal of pharmaceutics.

[11]  M. Kaplan,et al.  IL-4 Regulates Skin Homeostasis and the Predisposition toward Allergic Skin Inflammation , 2010, The Journal of Immunology.

[12]  I. Haeck,et al.  Severe atopic dermatitis treated with everolimus , 2009, The Journal of dermatological treatment.

[13]  R. Negrin,et al.  Role of naturally arising regulatory T cells in hematopoietic cell transplantation. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[14]  M. Steinhoff,et al.  Cytokines and chemokines orchestrate atopic skin inflammation. , 2006, The Journal of allergy and clinical immunology.

[15]  H. Yu,et al.  Transepidermal water loss, serum IgE and β‐endorphin as important and independent biological markers for development of itch intensity in atopic dermatitis , 2006, The British journal of dermatology.

[16]  M. Hecht,et al.  Cilomilast, tacrolimus and rapamycin modulate dendritic cell function in the elicitation phase of allergic contact dermatitis , 2005, The British journal of dermatology.

[17]  A. Ormerod,et al.  Treatment of psoriasis with topical sirolimus: preclinical development and a randomized, double‐blind trial , 2005, The British journal of dermatology.

[18]  Donald Y M Leung,et al.  Amendment history : Erratum ( April 2004 ) New insights into atopic dermatitis , 2018 .

[19]  T. Bieber,et al.  Atopic dermatitis , 2003, The Lancet.

[20]  R. Neubert,et al.  Topical application of mycophenolate mofetil in plaque‐type psoriasis , 2001, The British journal of dermatology.

[21]  R. Más,et al.  Anti-inflammatory activity of D-002: an active product isolated from beeswax. , 1998, Prostaglandins, leukotrienes, and essential fatty acids.

[22]  J. Ransom.  Mechanism of Action of Mycophenolate Mofetil , 1995, Therapeutic drug monitoring.

[23]  Y. Shoji,et al.  Effect of Topical Preparation of Mycophenolic Acid on Experimental Allergic Contact Dermatitis of Guinea‐pigs Induced by Dinitrofluorobenzene , 1994, The Journal of pharmacy and pharmacology.

[24]  G. Aversa,et al.  Brequinar Sodium, Mycophenolic Acid, and Cyclosporin A Inhibit Different Stages of IL‐4‐ or IL‐13‐Induced Human IgG4 and IgE Production In Vitro , 1993, Annals of the New York Academy of Sciences.

[25]  K. Ishizaka,et al.  IgE in atopic dermatitis. , 1971, Archives of dermatology.

[26]  K. Grice,et al.  Transepidermal water loss. , 1968, British medical journal.

[27]  D. Beeckman,et al.  A 3in-1 Perineal Care Washcloth Impregnated With Dimethicone 3 % Versus Water and pH Neutral Soap to Prevent and Treat Incontinence-Associated Dermatitis A Randomized , Controlled Clinical Trial , 2011 .

[28]  A. Thomson,et al.  Dendritic cells: emerging pharmacological targets of immunosuppressive drugs , 2004, Nature Reviews Immunology.

[29]  J. Meingassner,et al.  Anti-Inflammatory Effects of Macrophilin-lnteracting Drugs in Animal Models of Irritant and Allergic Contact Dermatitis. , 1992, International archives of allergy and immunology.

[30]  Thomas B. Fitzpatrick,et al.  Dermatology in general medicine , 1971 .